卡特-T疗法肺部不良事件概况:基于FAERS数据库 (2017-2023) 的药监测研究 (2017-2023)
Frontiers in pharmacology
|September 5, 2024
概括
化学抗原受体T细胞 (CAR-T) 治疗可以导致严重的肺部问题,如缺氧和呼吸衰竭. 这项研究分析了不良事件,发现Tisa-cel和Axi-cel与严重的肺事件有关,大多数发生在治疗后30天内.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 药物监督 药物监督 药物监督
背景情况:
- 化学抗原受体T细胞 (CAR-T) 疗法是2017年FDA批准的癌症治疗的重大进展.
- 虽然有效,但CAR-T疗法与可能危及生命的肺部不良事件 (PAE) 有关.
研究的目的:
- 调查与CAR-T细胞治疗相关的PAE的发生率和特征.
- 确定特定的CAR-T产品及其与不同肺部不良事件的相关性.
主要方法:
- 从2017年到2023年对FDA不良事件报告系统 (FAERS) 数据库的回顾性分析.
- 利用统计方法,包括报告几率比率和实证贝叶斯几何平均值来评估CAR-T疗法和PAE关联.
- 使用MedDRA 26.1编码进行不良事件分类.
主要成果:
- 在CAR-T疗法报告的9400次不良事件中,10% (940) 被确定为PAE.
- 缺氧 (344例) 和呼吸衰竭 (127例) 是最常见的PAE.
- Tisa-cel与呼吸衰竭和缺氧等严重事件有关,而Axi-cel与缺氧和短呼吸相关. 大多数PAE发生在治疗后30天内,Tisa-cel的死亡率最高 (43.6%).
结论:
- 卡尔-T细胞疗法与显著的肺部不良事件有关,包括缺氧,呼吸衰竭,多流液和.
- 这些发现强调了在接受CAR-T治疗的患者中监测PAE的临床重要性.
- 进一步的研究和临床警是有必要的,以管理和减轻这些风险.
更多相关视频
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
470
09:57Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
Published on: December 14, 2016
10.4K
相关概念视频
Pharmacovigilance
789
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
789
Drug Administration and Therapy Phases: Overview
418
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
418
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
187
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
187
Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)